‘Big Data’, Device Reprocessing Among FDA's Device Science Goals
This article was originally published in The Gray Sheet
Executive Summary
FDA’s device Center Science Council wants to leverage “big data” and evidence from real-world clinical experience, improve reprocessing of reusable medical devices and enhance use of health information technology and device cybersecurity, among other FY 2016 regulatory science goals.
You may also be interested in...
FDA Says It Is Changing Its Cybersecurity Culture, And Others Should Too
Speaking at the 2015 mHealth Summit, Suzanne Schwartz, the FDA device center's top cybersecurity expert, said the agency is undergoing a cultural shift to better deal with device cybersecurity vulnerabilities and urged manufacturers, security researchers and hospitals to do the same.
CDRH Science Council Explains Its Role, Responsibilities
CDRH's newly formed Center Science Council has a fairly ambitious to-do list, from developing processes for identifying and integrating new science into FDA reviews to designing new programs to improve clinical trials, according to a draft charter released March 31.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.